SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection
- PMID: 35020754
- PMCID: PMC8789181
- DOI: 10.1371/journal.ppat.1010242
SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection
Abstract
In-depth analysis of SARS-CoV-2 quasispecies is pivotal for a thorough understating of its evolution during infection. The recent deployment of COVID-19 vaccines, which elicit protective anti-spike neutralizing antibodies, has stressed the importance of uncovering and characterizing SARS-CoV-2 variants with mutated spike proteins. Sequencing databases have allowed to follow the spread of SARS-CoV-2 variants that are circulating in the human population, and several experimental platforms were developed to study these variants. However, less is known about the SARS-CoV-2 variants that are developed in the respiratory system of the infected individual. To gain further insight on SARS-CoV-2 mutagenesis during natural infection, we preformed single-genome sequencing of SARS-CoV-2 isolated from nose-throat swabs of infected individuals. Interestingly, intra-host SARS-CoV-2 variants with mutated S genes or N genes were detected in all individuals who were analyzed. These intra-host variants were present in low frequencies in the swab samples and were rarely documented in current sequencing databases. Further examination of representative spike variants identified by our analysis showed that these variants have impaired infectivity capacity and that the mutated variants showed varied sensitivity to neutralization by convalescent plasma and to plasma from vaccinated individuals. Notably, analysis of the plasma neutralization activity against these variants showed that the L1197I mutation at the S2 subunit of the spike can affect the plasma neutralization activity. Together, these results suggest that SARS-CoV-2 intra-host variants should be further analyzed for a more thorough characterization of potential circulating variants.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
![Fig 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8789181/bin/ppat.1010242.g001.gif)
![Fig 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8789181/bin/ppat.1010242.g002.gif)
![Fig 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8789181/bin/ppat.1010242.g003.gif)
![Fig 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8789181/bin/ppat.1010242.g004.gif)
![Fig 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8789181/bin/ppat.1010242.g005.gif)
![Fig 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8789181/bin/ppat.1010242.g006.gif)
Similar articles
-
Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies.J Virol. 2023 Dec 21;97(12):e0151123. doi: 10.1128/jvi.01511-23. Epub 2023 Nov 21. J Virol. 2023. PMID: 38092661 Free PMC article. Review.
-
Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers.EBioMedicine. 2022 Jan;75:103805. doi: 10.1016/j.ebiom.2021.103805. Epub 2022 Jan 12. EBioMedicine. 2022. PMID: 35032961 Free PMC article. Clinical Trial.
-
Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.Front Immunol. 2021 Dec 17;12:793191. doi: 10.3389/fimmu.2021.793191. eCollection 2021. Front Immunol. 2021. PMID: 34975897 Free PMC article.
-
Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects.Rev Med Virol. 2021 May;31(3):e2183. doi: 10.1002/rmv.2183. Epub 2020 Oct 15. Rev Med Virol. 2021. PMID: 33594794 Free PMC article. Review.
-
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.Elife. 2020 Oct 28;9:e61312. doi: 10.7554/eLife.61312. Elife. 2020. PMID: 33112236 Free PMC article.
Cited by
-
Incipient functional SARS-CoV-2 diversification identified through neural network haplotype maps.Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2317851121. doi: 10.1073/pnas.2317851121. Epub 2024 Feb 28. Proc Natl Acad Sci U S A. 2024. PMID: 38416684 Free PMC article.
-
SARS-CoV-2 quasi-species analysis from patients with persistent nasopharyngeal shedding.Sci Rep. 2022 Nov 4;12(1):18721. doi: 10.1038/s41598-022-22060-z. Sci Rep. 2022. PMID: 36333340 Free PMC article.
-
Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine.Vaccines (Basel). 2022 Jun 10;10(6):929. doi: 10.3390/vaccines10060929. Vaccines (Basel). 2022. PMID: 35746536 Free PMC article.
-
SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations.Pathogens. 2022 Jun 8;11(6):662. doi: 10.3390/pathogens11060662. Pathogens. 2022. PMID: 35745516 Free PMC article.
-
Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022.Emerg Infect Dis. 2022 Jul;28(7):1512-1515. doi: 10.3201/eid2807.220467. Epub 2022 May 6. Emerg Infect Dis. 2022. PMID: 35514025 Free PMC article.
References
-
- Li M, Chen L, Xiong C, Li X. The ACE2 expression of maternal-fetal interface and fetal organs indicates potential risk of vertical transmission of SARS-COV-2. bioRxiv. 2020;
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous